Nuwellis Beats Q4 Estimates with $2.42M Revenue

Revenue Beat: The company reported <strong class="body_output text-content_primary font-semibold" node="[object Object]">$2.42 million in revenue, exceeding the consensus estimate of $2.36 million.
Earnings Surprise: Actual earnings per share came in at <strong class="body_output text-content_primary font-semibold" node="[object Object]">-$1.50 , which was better than the anticipated loss of -$1.59 per share.
Reporting Period: The results cover the <strong class="body_output text-content_primary font-semibold" node="[object Object]">fourth quarter of fiscal year 2025 , providing the latest snapshot of the company&#x27;s financial health.

Nuwellis Exceeds Q4 Revenue Forecasts with $2.42M

Nuwellis Inc. (NUWE) reported fourth-quarter revenue of $2.42 million on March 10, 2026, surpassing analyst expectations of $2.36 million. The top-line figure represents a 2.7% beat over consensus forecasts, indicating stronger-than-anticipated sales performance for its medical device products during the period ending in 2025.

On the bottom line, the company posted a net loss of $1.50 per share for its fourth quarter. This result was significantly narrower than the projected loss of $1.59 per share that analysts had forecast. The positive earnings surprise of approximately $0.09 per share suggests more effective cost management or higher margins than Wall Street had modeled for the final quarter of the fiscal year.

Nuwellis Beats Q4 Estimates with $2.42M Revenue

Edgen Stock

Key Takeaways

Nuwellis Exceeds Q4 Revenue Forecasts with $2.42M

Nuwellis Exceeds Q4 Revenue Forecasts with $2.42M

Earnings Per Share Outperform Estimates at -$1.50